Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stressed-out endogenous cannabinoids relieve pain.

Christopher W Vaughan1

  • 1Pain Management Research Institute, Northern Clinical School, The University of Sydney at Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia. chrisv@med.usyd.edu.au

Trends in Pharmacological Sciences
|December 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fear-learning is altered in a mouse neuropathic pain model.

Frontiers in pain research (Lausanne, Switzerland)·2025
Same author

Preface to the special issue "Pain".

Journal of neurochemistry·2024
Same author

Disrupted stress-induced analgesia in a neuropathic pain state is rescued by the endocannabinoid degradation inhibitor JZL195.

Journal of neurochemistry·2024
Same author

Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence.

Journal of neurochemistry·2023
Same author

Cannabinoids and Opioids Differentially Target Extrinsic and Intrinsic GABAergic Inputs onto the Periaqueductal Grey Descending Pathway.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2022
Same author

Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.

International journal of molecular sciences·2022

Stress-induced analgesia (SIA) involves opioid and non-opioid pathways. New research shows midbrain endocannabinoids mediate non-opioid SIA, offering potential for new pain relief therapies.

Area of Science:

  • Neuroscience
  • Pain Research
  • Pharmacology

Background:

  • Stressful stimuli activate descending pathways from the brain to the spinal cord, inducing analgesia.
  • Stress-induced analgesia (SIA) is known to operate through both opioid-dependent and non-opioid-dependent mechanisms.

Purpose of the Study:

  • To investigate the role of endocannabinoids in the midbrain for non-opioid SIA.
  • To explore the therapeutic potential of targeting endocannabinoid breakdown for pain management.

Main Methods:

  • Utilized rodent models to study stress-induced analgesia.
  • Investigated the involvement of specific endocannabinoids in the midbrain.
  • Examined the effects of agents that inhibit endocannabinoid degradation.

Related Experiment Videos

Main Results:

  • Identified two distinct endocannabinoids in the midbrain as key mediators of non-opioid SIA.
  • Demonstrated that inhibiting the breakdown of these endocannabinoids significantly enhances non-opioid SIA.
  • Provided evidence for a novel neurobiological pathway underlying stress-induced pain relief.

Conclusions:

  • Non-opioid stress-induced analgesia is mediated by specific midbrain endocannabinoids.
  • Agents that prevent endocannabinoid breakdown represent a promising therapeutic strategy for enhancing pain relief.